Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.
Shirin ArdeshirrouhanifardHuijun AnRavi K GoyalMukaila A RajiJodi B SegalG Caleb AlexanderHemalkumar B MehtaPublished in: Pharmacotherapy (2022)
Nearly 7 out of 10 patients with cancer and NVAF did not receive anticoagulation. Use of DOACs increased from 2010 to 2016, with a corresponding decline in warfarin use. DOACs are used less than warfarin among those at higher risk of stroke.
Keyphrases